(Q79075118)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14501770%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

review article

1 reference

title

Androgen receptors in prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14501770%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Androgen Receptors in Prostate Cancer (English)

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

12 March 2024

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

12 March 2024

author name string

Zoran Culig

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14501770%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Helmut Klocker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14501770%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Georg Bartsch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14501770%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Hannes Steiner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14501770%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Alfred Hobisch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14501770%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14501770

12 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14501770%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 December 2019

http://api.elsevier.com/content/article/PII:S0022534705631801?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

http://api.elsevier.com/content/article/PII:S0022534705631801?httpAccept=text/plain

12 March 2024

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

http://www.jurology.com/doi/pdf/10.1097/01.ju.0000075099.20662.7f

12 March 2024

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

12 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14501770%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14501770%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

4 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14501770%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

1363-1369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14501770%20AND%20SRC:MED&resulttype=core&format=json

Both androgen receptor and glucocorticoid receptor are able to induce prostate-specific antigen expression, but differ in their growth-stimulating properties of LNCaP cells

19 December 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer

12 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China

12 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

(CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French–German population

12 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions

12 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells

12 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy

12 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer

12 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.

12 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6

12 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells

12 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells

12 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform

12 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Linking beta-catenin to androgen-signaling pathway

12 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

From estrogen to androgen receptor: a new pathway for sex hormones in prostate

12 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells

12 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer

12 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells.

12 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells

12 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

The amino terminus of the human AR is target for corepressor action and antihormone agonism

12 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

12 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor

12 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes

12 March 2024

30

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Activation of the human androgen receptor through a protein kinase A signaling pathway

12 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor

12 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells

12 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Interleukin-6 is an autocrine growth factor in human prostate cancer.

12 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Characterization of the role of IL-6 in the progression of prostate cancer

12 March 2024

35

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Beta-catenin affects androgen receptor transcriptional activity and ligand specificity

12 March 2024

38

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Antagonism between PTEN/MMAC1/TEP-1 and androgen receptor in growth and apoptosis of prostatic cancer cells

12 March 2024

39

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase

12 March 2024

40

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation

12 March 2024

41

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

E2F activity is biphasically regulated by androgens in LNCaP cells

12 March 2024

43

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer

12 March 2024

45

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest

12 March 2024

46

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system

12 March 2024

47

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor

12 March 2024

49

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells

12 March 2024

53

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells

12 March 2024

54

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides

12 March 2024

57

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts

12 March 2024

59

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells

12 March 2024

60

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells

12 March 2024

61

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model

12 March 2024

63

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer

12 March 2024

64

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER

12 March 2024

65

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

12 March 2024

66

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.

12 March 2024

67

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction

12 March 2024

68

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence

12 March 2024

69

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer

12 March 2024

70

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Aberrant response in vitro of hormone-responsive prostate cancer cells to antiandrogens

12 March 2024

71

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist

12 March 2024

72

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

12 March 2024

73

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line

12 March 2024

74

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene

12 March 2024

75

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000075099.20662.7F

12 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14501770%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference